Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis

Abstract

The authors describe the efficacy and safety of subcutaneous administration idrabiotaparinux weekly in patients with symptomatic deep venous thrombosis.

Keywords

• anticoagulants
• bioequipotency
• deep venous thrombosis
• treatment randomized trial